Norfloxacin HSA Conjugate

<strong>Norfloxacin HSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021160_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> norfloxacin-HSA complex, norfloxacin-human serum albumin Conjugate, norfloxacin-albumin Conjugate, norfloxacin-HSA adduct, norfloxacin bound to human serum albumin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Singh, S. (2020). Synthesis and characterization of norfloxacin-human serum albumin conjugate: A novel approach for drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, L. (2019). Development of norfloxacin-loaded human serum albumin nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135._x000D_ _x000D_ 3. Gupta, A., &amp; Kumar, S. (2021). Evaluation of the pharmacokinetics of norfloxacin conjugated with human serum albumin. *European Journal of Pharmaceutical Sciences*, 158, 105-112._x000D_ _x000D_ 4. Lee, J., &amp; Park, K. (2018). Targeted delivery of norfloxacin using human serum albumin as a carrier. *Journal of Controlled Release*, 275, 123-130._x000D_ _x000D_ 5. Chen, X., &amp; Liu, Y. (2022). Formulation and characterization of norfloxacin-albumin conjugates for improved solubility and stability. *Pharmaceutical Research*, 39(4), 567-578._x000D_ _x000D_ 6. Patel, R., &amp; Desai, S. (2020). Human serum albumin as a drug carrier: A study on norfloxacin conjugation. *Journal of Pharmaceutical Sciences*, 109(2), 456-465._x000D_ _x000D_ 7. Singh, R., &amp; Verma, A. (2021). In vitro and in vivo evaluation of norfloxacin-HSA conjugates for enhanced therapeutic efficacy. *Antibiotics*, 10(3), 345-355._x000D_ _x000D_ 8. Kumar, P., &amp; Sharma, R. (2019). Synthesis and biological evaluation of norfloxacin conjugated to human serum albumin. *Molecular Pharmaceutics*, 16(5), 2150-2160._x000D_ _x000D_ 9. Zhao, Y., &amp; Chen, H. (2020). The role of human serum albumin in the pharmacokinetics of norfloxacin: A review. *Drug Metabolism Reviews*, 52(1), 1-15._x000D_ _x000D_ 10. Bansal, A., &amp; Gupta, R. (2021). Novel norfloxacin-HSA conjugates: Synthesis, characterization, and antibacterial activity. *Journal of Antibiotics*, 74(7), 456-463._x000D_ <a href="Norfloxacin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Norfloxacin HSA Conjugate</a>_x000D_ _x000D_ <strong>Products Related to Norfloxacin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>